Revenue
0 USD
2026 Q3 · USD
Exact inputs and evidence
- Revenue: 0 USD Source
Annual consolidated revenue for 2025: about USD 65.56K, using the latest reported figures. The previous period, 2024, was about USD 4.241K.
81494 USD
102355323 shares
6.71% · 6.43 million shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.
55.7 thousand USD
2025-08-01 – 2026-07-31
-1.35 million USD
2025-08-01 – 2026-07-31
-520 thousand USD
2025-08-01 – 2026-07-31
63.2 thousand USD
2025-05-01 – 2026-04-30
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2026-09-21.
Financial data available through: 2025-10-31.
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Prior period
USD 4,241
–
Current period
USD 65,561
–
65561 − 4241 = 61320 USD
4241 USD · 2023-11-01 – 2024-10-31
Inspect prior input Prior source65561 USD · 2024-11-01 – 2025-10-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 3.34 million
–
Current period
−USD 6.62 million
–
-6615496 − -3338590 = -3276906 USD
-3338590 USD · 2023-11-01 – 2024-10-31
Inspect prior input Prior source-6615496 USD · 2024-11-01 – 2025-10-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 1.8 million
–
Current period
−USD 960,488
–
-960488 − -1802678 = 842190 USD
-1802678 USD · 2023-11-01 – 2024-10-31
Inspect prior input Prior source-960488 USD · 2024-11-01 – 2025-10-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
USD 381,934
–
Current period
USD 227,943
–
227943 − 381934 = -153991 USD
381934 USD · 2023-11-01 – 2024-10-31
Inspect prior input Prior source227943 USD · 2024-11-01 – 2025-10-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2021 2020-11-01 – 2021-10-31 | 0 | 132932 Derived | -132932 | 0 Derived | -132932 | Unavailable | Source
|
| 2022 2021-11-01 – 2022-10-31 | 34450 | 1105759 Derived | -1071309 | 0 Derived | -1071309 | -1121708 Derived | Source
|
| 2023 2022-11-01 – 2023-10-31 | 13000 | 1940494 Derived | -1927494 | 0 Derived | -1927494 | -2138962 Derived | Source
|
| 2024 2023-11-01 – 2024-10-31 | 4241 | 3342831 Derived | -3338590 | 0 Derived | -3338590 | -2184612 Derived | Source
|
| 2025 2024-11-01 – 2025-10-31 | 65561 | 6681057 Derived | -6615496 | 0 Derived | -6615496 | -1188431 Derived | Source
|
Amounts are exact, in USD.
Sales over time and how quickly they are changing.
Revenue reported for each complete financial period.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2021 | Revenue | 0 |
|
| 2022 | Revenue | 34450 |
|
| 2023 | Revenue | 13000 |
|
| 2024 | Revenue | 4241 |
|
| 2025 | Revenue | 65561 |
|
Change in revenue from the same financial period one year earlier.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2021 | Year over year | No prior comparable period |
|
| 2022 | Year over year | No prior comparable period |
|
| 2023 | Year over year | -62.3% |
|
| 2024 | Year over year | -67.4% |
|
| 2025 | Year over year | 1,445.9% |
|
How much revenue becomes profit, and how much cash operations generate.
Operating income, net income and free cash flow as a share of revenue.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2021 | Operating margin | Not reported |
|
| 2022 | Operating margin | -3,109.8% |
|
| 2023 | Operating margin | -14,826.9% |
|
| 2024 | Operating margin | -78,721.8% |
|
| 2025 | Operating margin | -10,090.6% |
|
| 2021 | Net margin | Not reported |
|
| 2022 | Net margin | -3,109.8% |
|
| 2023 | Net margin | -14,826.9% |
|
| 2024 | Net margin | -78,721.8% |
|
| 2025 | Net margin | -10,090.6% |
|
| 2021 | Free cash flow margin | Not reported |
|
| 2022 | Free cash flow margin | -3,256% |
|
| 2023 | Free cash flow margin | -16,453.6% |
|
| 2024 | Free cash flow margin | -51,511.7% |
|
| 2025 | Free cash flow margin | -1,812.7% |
|
Cash generated by the company’s normal business operations.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2021 | Operating cash flow | -37859 |
|
| 2022 | Operating cash flow | -1121708 |
|
| 2023 | Operating cash flow | -1334084 |
|
| 2024 | Operating cash flow | -1802678 |
|
| 2025 | Operating cash flow | -960488 |
|
Operating cash flow minus capital expenditure for the same period and unit.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2021 | Free cash flow | Unavailable |
|
| 2022 | Free cash flow | -1121708 |
|
| 2023 | Free cash flow | -2138962 |
|
| 2024 | Free cash flow | -2184612 |
|
| 2025 | Free cash flow | -1188431 |
|
Liabilities and short-term ability to meet obligations at each period end.
Total liabilities as a share of total assets.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2021 | Liabilities / assets | Not reported |
|
| 2022 | Liabilities / assets | 1,071.5% |
|
| 2023 | Liabilities / assets | 115.3% |
|
| 2024 | Liabilities / assets | 211.9% |
|
| 2025 | Liabilities / assets | 194.2% |
|
Current assets divided by current liabilities.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2021 | Current assets / current liabilities | 0× |
|
| 2022 | Current assets / current liabilities | 0.17× |
|
| 2023 | Current assets / current liabilities | 0.34× |
|
| 2024 | Current assets / current liabilities | 0.01× |
|
| 2025 | Current assets / current liabilities | 0.12× |
|
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2021 2020-11-01 – 2021-10-31 | −USD 132,932 Exact valueExact value: -132932 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 37,859 Exact valueExact value: -37859 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2022 2021-11-01 – 2022-10-31 | −USD 1.07 million Exact valueExact value: -1071309 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 1.12 million Exact valueExact value: -1121708 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 0 Exact valueExact value: -0 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 1.12 million Calculation and evidence-1121708 − -0 USD Exact free cash flow: -1121708 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2023 2022-11-01 – 2023-10-31 | −USD 1.93 million Exact valueExact value: -1927494 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 1.33 million Exact valueExact value: -1334084 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 804,878 Exact valueExact value: 804878 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 2.14 million Calculation and evidence-1334084 − 804878 USD Exact free cash flow: -2138962 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2024 2023-11-01 – 2024-10-31 | −USD 3.34 million Exact valueExact value: -3338590 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 1.8 million Exact valueExact value: -1802678 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 381,934 Exact valueExact value: 381934 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 2.18 million Calculation and evidence-1802678 − 381934 USD Exact free cash flow: -2184612 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2025 2024-11-01 – 2025-10-31 | −USD 6.62 million Exact valueExact value: -6615496 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 960,488 Exact valueExact value: -960488 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 227,943 Exact valueExact value: 227943 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 1.19 million Calculation and evidence-960488 − 227943 USD Exact free cash flow: -1188431 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
51 filings · 1,106 latest values · 1,106 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001342916, 1342916, HNOI, crge, edgar:1342916
Also known as American Bonanza Resources Corp., CLENERGEN Corp, Clenergen Corp, HNO INTERNATIONAL, INC., HNO International, Inc.